Indo Us Biotech Limited has informed the Exchange about General Updates_MOU between INDOUS and ICAR-IARI for the maize hybrid HQPM-5 variety.
INDOUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Indo Us Biotech Limited has signed a Memorandum of Understanding (MOU) with ICAR-IARI (Indian Agricultural Research Institute) on 9th July 2025 for the maize hybrid HQPM-5 variety. The MOU was signed by Executive Director Mrs. Priyanka Ajudia and Promoter Mr. Samarth Patel in the presence of Dr. Vishwanathan from ICAR-IARI. This collaboration aims to bring high-quality, high-yielding maize seed varieties to farmers across India. ICAR-IARI is one of India's most prestigious agricultural research institutions, lending significant credibility to the partnership.
This is a positive development for the company as partnering with ICAR-IARI, a premier government research body, strengthens the company's seed portfolio and brand credibility. However, since this is only an MOU and not a commercial deal or revenue-generating contract, the immediate impact on stock price or financials may be limited.